The FDA 510(k) database entry for K260758 identifies Siemens Shenzhen Magnetic Resonance, Ltd. as the applicant for MAGNETOM Free.Max and MAGNETOM Free.Star, a nuclear magnetic resonance imaging system under product code LNH and regulation number 892.1000, device class 2, in the radiology specialty. The record gives a decision date of September 1, 2026, decision code SESE, and describes the decision as substantially equivalent. The applicant address in the filing is in Shenzhen, with postal code 518057; that is a filing address, not a verified headquarters. [1]

Documented clearance and review path

The K260758 record shows a traditional clearance type, a third-party review flag of N, and a summary statement. The application was received March 9, 2026, and decided September 1, 2026. The advisory committee is listed as radiology, and the device name in the openFDA fields is given as system, nuclear magnetic resonance imaging. [1]

The FDA clearance letter for K260758 is addressed to Siemens Shenzhen Magnetic Resonance, Ltd. care of Martin Rajchel, senior manager, regulatory affairs, at Siemens Medical Solutions USA, Inc. in Malvern, Pennsylvania. The letter names MAGNETOM Free.Max and MAGNETOM Free.Star, cites 21 CFR 892.1000 as a Class II magnetic resonance diagnostic device, and lists product codes LNH and MOS. [2]

Predicate basis and software version

The K260758 letter states that the subject devices with software Syngo MR XB10 are substantially equivalent to a predicate, MAGNETOM Free.Max with syngo MR XA80A, cleared as K251822 on November 20, 2025, under product codes LNH and MOS, with Siemens Shenzhen Magnetic Resonance Ltd. as the predicate manufacturer. [2]

The earlier K251822 clearance letter, dated November 20, 2025, carries the same trade names, regulation number, class and product codes, and is addressed to Siemens Shenzhen Magnetic Resonance Ltd. care of a regulatory affairs professional at Siemens Medical Solutions USA, Inc. in Malvern. Its listed predicate chain includes syngo.via VB40A under K191040, cleared May 16, 2019, with Siemens Healthcare GmbH as manufacturer. [5]

Earlier filings under the same trade names

A November 9, 2023 clearance letter for K231617 names MAGNETOM Free.Max and MAGNETOM Free.Star under 21 CFR 892.1000, Class II, product codes LNH and MOS, and is addressed to Siemens Medical Solutions USA, Inc. in Malvern. The letter lists standards references, including IEC 60601-1 and collateral electromagnetic disturbance requirements, and Part 2-33 particular requirements for magnetic resonance equipment. [7]

A June 24, 2022 clearance letter for K220575 names MAGNETOM Free.Max with syngo MR XA50A and MAGNETOM Free.Star with syngo MR XA50A, again under 21 CFR 892.1000, Class II, product codes LNH and MOS. That letter identifies MAGNETOM Free.Max with syngo MR XA40A, cleared as K210611 on July 1, 2021, as the predicate system for magnetic resonance features and functionalities. [9]

What the collection does and does not show

The linked collection for this applicant contains one 510(k) record, K260758, and its decision count is one SESE decision; the record sample likewise holds that single entry. These figures describe the linked filings as of the snapshot and are not measures of total company sales, total portfolio or safety performance. No recall records appear in the linked sample. [1]

The FDA records establish the applicant identity and the named device families across several clearances, but they do not establish a corporate parent relationship, headquarters, website, customers or commercial availability. Siemens Medical Solutions USA, Inc. appears only as the correspondence address in the clearance letters, and Siemens Healthcare GmbH appears as a predicate manufacturer, not as a verified owner of the applicant. [2][5][7]